4.7 Article

Perivascular Macrophages Regulate Blood Flow Following Tissue Damage

Journal

CIRCULATION RESEARCH
Volume 128, Issue 11, Pages 1694-1707

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.120.318380

Keywords

ischemia; morbidity; perfusion; peripheral artery disease; plasmids

Funding

  1. Swedish Research Council [K2012-99x, 65X12219-15-6, 5570x-15043, O4X-08646, K2015-54X-12219-19-4]
  2. Ragnar Soderberg foundation
  3. Knut and Alice Wallenberg foundation
  4. Swedish Foundation for Strategic Research
  5. Diabetes Wellness Sweden
  6. Swedish national strategic research initiative (EXODIAB-Excellence Of Diabetes Research in Sweden)
  7. Juvenile Diabetes Research Foundation
  8. Novo Nordisk Foundation
  9. Swedish Society for Medical Research
  10. Thuring Foundation
  11. Family Ernfors Foundation
  12. Kuopio University Hospital Catchment Area State Clinical Research Funding
  13. Swedish Diabetes Association

Ask authors/readers for more resources

This study reveals a novel role of macrophages in regulating blood flow by releasing iNOS in ischemic muscles to improve tissue perfusion and repair. Depletion of iNOS in macrophages compromised blood flow regulation and exacerbated ischemic damage in the muscles.
Rationale: Ischemic injuries remain a leading cause of mortality and morbidity worldwide, and restoration of functional blood perfusion is vital to limit tissue damage and support healing. Objective: To reveal a novel role of macrophages in reestablishment of functional tissue perfusion following ischemic injury that can be targeted to improve tissue restoration. Methods and Results: Using intravital microscopy of ischemic hindlimb muscle in mice, and confocal microscopy of human tissues from amputated legs, we found that macrophages accumulated perivascularly in ischemic muscles, where they expressed high levels of iNOS (inducible nitric oxide [NO] synthase). Genetic depletion of iNOS specifically in macrophages (Cx3cr1-CreERT2;Nos2(fl/fl) or LysM-Cre;Nos2(fl/fl)) did not affect vascular architecture but highly compromised blood flow regulation in ischemic but not healthy muscle, which resulted in aggravated ischemic damage. Thus, the ability to upregulate blood flow was shifted from eNOS (endothelial)-dependence in healthy muscles to completely rely on macrophage-derived iNOS during ischemia. Macrophages in ischemic muscles expressed high levels of CXCR4 (C-X-C chemokine receptor type 4) and CCR2 (C-C chemokine receptor type 2), and local overexpression by DNA plasmids encoding the corresponding chemokines CXCL12 (stromal-derived factor 1) or CCL2 (chemokine [C-C motif] ligand 2) increased macrophage numbers, while CXCL12 but not CCL2 induced their perivascular positioning. As a result, CXCL12-overexpression increased the number of perfused blood vessels in the ischemic muscles, improved functional muscle perfusion in a macrophage-iNOS-dependent manner, and ultimately restored limb function. Conclusions: This study establishes a new function for macrophages during tissue repair, as they regulate blood flow through the release of iNOS-produced NO. Further, we demonstrate that macrophages can be therapeutically targeted to improve blood flow regulation and functional recovery of ischemic tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available